Software - Application
Compare Stocks
5 / 10Stock Comparison
RSKD vs NICE vs AMZN vs FIVN vs MSFT
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Specialty Retail
Software - Infrastructure
Software - Infrastructure
RSKD vs NICE vs AMZN vs FIVN vs MSFT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Software - Application | Specialty Retail | Software - Infrastructure | Software - Infrastructure |
| Market Cap | $825M | $5.78B | $2.92T | $1.70B | $3.13T |
| Revenue (TTM) | $345M | $2.95B | $742.78B | $1.17B | $318.27B |
| Net Income (TTM) | $-28M | $612M | $90.80B | $57M | $125.22B |
| Gross Margin | 51.5% | 66.4% | 50.6% | 55.1% | 68.3% |
| Operating Margin | -9.8% | 21.9% | 11.5% | 4.7% | 46.8% |
| Forward P/E | 20.8x | 8.7x | 34.8x | 7.0x | 25.3x |
| Total Debt | $25M | $164M | $152.99B | $847M | $112.18B |
| Cash & Equiv. | $162M | $379M | $86.81B | $232M | $30.24B |
RSKD vs NICE vs AMZN vs FIVN vs MSFT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 21 | May 26 | Return |
|---|---|---|---|
| Riskified Ltd. (RSKD) | 100 | 17.6 | -82.4% |
| NICE Ltd. (NICE) | 100 | 34.3 | -65.7% |
| Amazon.com, Inc. (AMZN) | 100 | 163.0 | +63.0% |
| Five9, Inc. (FIVN) | 100 | 11.0 | -89.0% |
| Microsoft Corporati… (MSFT) | 100 | 147.7 | +47.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RSKD vs NICE vs AMZN vs FIVN vs MSFT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RSKD lags the leaders in this set but could rank higher in a more targeted comparison.
NICE is the #2 pick in this set and the best alternative if sleep-well-at-night and valuation efficiency is your priority.
- Lower volatility, beta 0.72, Low D/E 4.2%, current ratio 1.55x
- PEG 0.33 vs MSFT's 1.35
- Beta 0.72, current ratio 1.55x
- Lower P/E (8.7x vs 25.3x), PEG 0.33 vs 1.35
AMZN ranks third and is worth considering specifically for momentum.
- +43.7% vs NICE's -40.4%
FIVN is the clearest fit if your priority is growth exposure.
- Rev growth 10.3%, EPS growth 370.6%, 3Y rev CAGR 13.8%
MSFT carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 19 yrs, beta 0.89, yield 0.8%
- 7.9% 10Y total return vs AMZN's 7.0%
- 14.9% revenue growth vs RSKD's 5.2%
- 39.3% margin vs RSKD's -8.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 14.9% revenue growth vs RSKD's 5.2% | |
| Value | Lower P/E (8.7x vs 25.3x), PEG 0.33 vs 1.35 | |
| Quality / Margins | 39.3% margin vs RSKD's -8.0% | |
| Stability / Safety | Beta 0.72 vs FIVN's 1.79, lower leverage | |
| Dividends | 0.8% yield; 19-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +43.7% vs NICE's -40.4% | |
| Efficiency (ROA) | 19.2% ROA vs RSKD's -6.3%, ROIC 24.9% vs -22.2% |
RSKD vs NICE vs AMZN vs FIVN vs MSFT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
RSKD vs NICE vs AMZN vs FIVN vs MSFT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MSFT leads in 3 of 6 categories
NICE leads 1 • AMZN leads 1 • RSKD leads 0 • FIVN leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MSFT leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMZN is the larger business by revenue, generating $742.8B annually — 2155.2x RSKD's $345M. MSFT is the more profitable business, keeping 39.3% of every revenue dollar as net income compared to RSKD's -8.0%. On growth, MSFT holds the edge at +18.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $345M | $2.9B | $742.8B | $1.2B | $318.3B |
| EBITDAEarnings before interest/tax | -$27M | $845M | $155.9B | $140M | $192.6B |
| Net IncomeAfter-tax profit | -$28M | $612M | $90.8B | $57M | $125.2B |
| Free Cash FlowCash after capex | $34M | $665M | -$2.5B | $206M | $72.9B |
| Gross MarginGross profit ÷ Revenue | +51.5% | +66.4% | +50.6% | +55.1% | +68.3% |
| Operating MarginEBIT ÷ Revenue | -9.8% | +21.9% | +11.5% | +4.7% | +46.8% |
| Net MarginNet income ÷ Revenue | -8.0% | +20.8% | +12.2% | +4.9% | +39.3% |
| FCF MarginFCF ÷ Revenue | +9.9% | +22.6% | -0.3% | +17.6% | +22.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.2% | +9.0% | +16.6% | +9.2% | +18.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.5% | +56.5% | +74.8% | +20.0% | +23.4% |
Valuation Metrics
NICE leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 9.9x trailing earnings, NICE trades at a 80% valuation discount to FIVN's 48.3x P/E. Adjusting for growth (PEG ratio), NICE offers better value at 0.37x vs MSFT's 1.64x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $825M | $5.8B | $2.92T | $1.7B | $3.13T |
| Enterprise ValueMkt cap + debt − cash | $687M | $5.6B | $2.98T | $2.3B | $3.21T |
| Trailing P/EPrice ÷ TTM EPS | -26.81x | 9.89x | 37.82x | 48.26x | 30.86x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.80x | 8.74x | 34.77x | 6.96x | 25.34x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.37x | 1.35x | — | 1.64x |
| EV / EBITDAEnterprise value multiple | — | 6.59x | 20.47x | 16.84x | 19.72x |
| Price / SalesMarket cap ÷ Revenue | 2.39x | 1.96x | 4.07x | 1.48x | 11.10x |
| Price / BookPrice ÷ Book value/share | 2.58x | 1.56x | 7.14x | 2.46x | 9.15x |
| Price / FCFMarket cap ÷ FCF | 24.94x | 8.22x | 378.98x | 8.45x | 43.66x |
Profitability & Efficiency
MSFT leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MSFT delivers a 33.1% return on equity — every $100 of shareholder capital generates $33 in annual profit, vs $-8 for RSKD. NICE carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to FIVN's 1.08x. On the Piotroski fundamental quality scale (0–9), FIVN scores 8/9 vs RSKD's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -8.4% | +16.4% | +23.3% | +7.4% | +33.1% |
| ROA (TTM)Return on assets | -6.3% | +11.8% | +11.5% | +3.2% | +19.2% |
| ROICReturn on invested capital | -22.2% | +13.2% | +14.7% | +1.7% | +24.9% |
| ROCEReturn on capital employed | -7.6% | +16.1% | +15.3% | +2.2% | +29.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 6 | 8 | 6 |
| Debt / EquityFinancial leverage | 0.08x | 0.04x | 0.37x | 1.08x | 0.33x |
| Net DebtTotal debt minus cash | -$137M | -$216M | $66.2B | $615M | $81.9B |
| Cash & Equiv.Liquid assets | $162M | $379M | $86.8B | $232M | $30.2B |
| Total DebtShort + long-term debt | $25M | $164M | $153.0B | $847M | $112.2B |
| Interest CoverageEBIT ÷ Interest expense | — | — | 39.96x | 7.94x | 55.65x |
Total Returns (Dividends Reinvested)
AMZN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MSFT five years ago would be worth $17,246 today (with dividends reinvested), compared to $1,305 for FIVN. Over the past 12 months, AMZN leads with a +43.7% total return vs NICE's -40.4%. The 3-year compound annual growth rate (CAGR) favors AMZN at 36.8% vs FIVN's -27.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +0.3% | -14.6% | +19.7% | +18.0% | -10.8% |
| 1-Year ReturnPast 12 months | +2.0% | -40.4% | +43.7% | -11.9% | -2.1% |
| 3-Year ReturnCumulative with dividends | +2.2% | -49.3% | +156.2% | -61.4% | +39.5% |
| 5-Year ReturnCumulative with dividends | -81.4% | -59.1% | +64.8% | -87.0% | +72.5% |
| 10-Year ReturnCumulative with dividends | -81.4% | +50.7% | +697.8% | +125.4% | +787.7% |
| CAGR (3Y)Annualised 3-year return | +0.7% | -20.2% | +36.8% | -27.2% | +11.7% |
Risk & Volatility
Evenly matched — NICE and AMZN each lead in 1 of 2 comparable metrics.
Risk & Volatility
NICE is the less volatile stock with a 0.72 beta — it tends to amplify market swings less than FIVN's 1.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMZN currently trades 97.3% from its 52-week high vs NICE's 53.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.05x | 0.72x | 1.51x | 1.79x | 0.89x |
| 52-Week HighHighest price in past year | $5.68 | $180.61 | $278.56 | $30.38 | $555.45 |
| 52-Week LowLowest price in past year | $3.70 | $94.89 | $185.01 | $13.29 | $356.28 |
| % of 52W HighCurrent price vs 52-week peak | +84.9% | +53.0% | +97.3% | +73.1% | +75.8% |
| RSI (14)Momentum oscillator 0–100 | 63.8 | 40.9 | 81.1 | 68.1 | 54.0 |
| Avg Volume (50D)Average daily shares traded | 763K | 631K | 45.5M | 2.8M | 32.5M |
Analyst Outlook
MSFT leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: RSKD as "Buy", NICE as "Buy", AMZN as "Buy", FIVN as "Buy", MSFT as "Buy". Consensus price targets imply 57.8% upside for NICE (target: $151) vs 13.1% for AMZN (target: $307). MSFT is the only dividend payer here at 0.77% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $5.75 | $150.88 | $306.77 | $28.40 | $551.75 |
| # AnalystsCovering analysts | 11 | 23 | 94 | 41 | 81 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +0.8% |
| Dividend StreakConsecutive years of raises | — | 0 | — | — | 19 |
| Dividend / ShareAnnual DPS | — | — | — | — | $3.23 |
| Buyback YieldShare repurchases ÷ mkt cap | +12.9% | +8.5% | 0.0% | +2.9% | +0.6% |
MSFT leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NICE leads in 1 (Valuation Metrics). 1 tied.
RSKD vs NICE vs AMZN vs FIVN vs MSFT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is RSKD or NICE or AMZN or FIVN or MSFT a better buy right now?
For growth investors, Microsoft Corporation (MSFT) is the stronger pick with 14.
9% revenue growth year-over-year, versus 5. 2% for Riskified Ltd. (RSKD). NICE Ltd. (NICE) offers the better valuation at 9. 9x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate Riskified Ltd. (RSKD) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RSKD or NICE or AMZN or FIVN or MSFT?
On trailing P/E, NICE Ltd.
(NICE) is the cheapest at 9. 9x versus Five9, Inc. at 48. 3x. On forward P/E, Five9, Inc. is actually cheaper at 7. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NICE Ltd. wins at 0. 33x versus Microsoft Corporation's 1. 35x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — RSKD or NICE or AMZN or FIVN or MSFT?
Over the past 5 years, Microsoft Corporation (MSFT) delivered a total return of +72.
5%, compared to -87. 0% for Five9, Inc. (FIVN). Over 10 years, the gap is even starker: MSFT returned +787. 7% versus RSKD's -81. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RSKD or NICE or AMZN or FIVN or MSFT?
By beta (market sensitivity over 5 years), NICE Ltd.
(NICE) is the lower-risk stock at 0. 72β versus Five9, Inc. 's 1. 79β — meaning FIVN is approximately 147% more volatile than NICE relative to the S&P 500. On balance sheet safety, NICE Ltd. (NICE) carries a lower debt/equity ratio of 4% versus 108% for Five9, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — RSKD or NICE or AMZN or FIVN or MSFT?
By revenue growth (latest reported year), Microsoft Corporation (MSFT) is pulling ahead at 14.
9% versus 5. 2% for Riskified Ltd. (RSKD). On earnings-per-share growth, the picture is similar: Five9, Inc. grew EPS 370. 6% year-over-year, compared to 10. 0% for Riskified Ltd.. Over a 3-year CAGR, FIVN leads at 13. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RSKD or NICE or AMZN or FIVN or MSFT?
Microsoft Corporation (MSFT) is the more profitable company, earning 36.
1% net margin versus -8. 0% for Riskified Ltd. — meaning it keeps 36. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSFT leads at 45. 6% versus -8. 4% for RSKD. At the gross margin level — before operating expenses — MSFT leads at 68. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RSKD or NICE or AMZN or FIVN or MSFT more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, NICE Ltd. (NICE) is the more undervalued stock at a PEG of 0. 33x versus Microsoft Corporation's 1. 35x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Five9, Inc. (FIVN) trades at 7. 0x forward P/E versus 34. 8x for Amazon. com, Inc. — 27. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NICE: 57. 8% to $150. 88.
08Which pays a better dividend — RSKD or NICE or AMZN or FIVN or MSFT?
In this comparison, MSFT (0.
8% yield) pays a dividend. RSKD, NICE, AMZN, FIVN do not pay a meaningful dividend and should not be held primarily for income.
09Is RSKD or NICE or AMZN or FIVN or MSFT better for a retirement portfolio?
For long-horizon retirement investors, Microsoft Corporation (MSFT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
89), 0. 8% yield, +787. 7% 10Y return). Five9, Inc. (FIVN) carries a higher beta of 1. 79 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MSFT: +787. 7%, FIVN: +125. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RSKD and NICE and AMZN and FIVN and MSFT?
These companies operate in different sectors (RSKD (Technology) and NICE (Technology) and AMZN (Consumer Cyclical) and FIVN (Technology) and MSFT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: RSKD is a small-cap quality compounder stock; NICE is a small-cap deep-value stock; AMZN is a mega-cap quality compounder stock; FIVN is a small-cap quality compounder stock; MSFT is a mega-cap quality compounder stock. MSFT pays a dividend while RSKD, NICE, AMZN, FIVN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.